Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary

被引：0
|
作者：
Tariot, PN
Doody, R
Peskind, ER
Winblad, B
Stöffler, A
Graham, SM
Jonas, JM
McDonald, S
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Huddinge Hosp, Karolinska Inst, S-14186 Huddinge, Sweden
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [31] Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients
    Ferris, Steven
    Ihl, Ralf
    Robert, Philippe
    Winblad, Bengt
    Gatz, Gudrun
    Tennigkeit, Frank
    Gauthier, Serge
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 369 - 374
  • [32] Efficacy of memantine in moderate to severe Alzheimer's disease
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 318 - 318
  • [33] Memantine in moderate-to-severe Alzheimer's disease
    Reisberg, B
    Doody, R
    Stoffler, A
    Schmitt, F
    Ferris, S
    Mobius, HJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14): : 1333 - 1341
  • [34] Functional benefit of memantine treatment in patients with moderate to severe Alzheimer's disease
    Wirth, Y
    Doody, RS
    Schmitt, FA
    Moebius, HJ
    Stoeffler, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S327 - S327
  • [35] Memantine therapy in patients with severe Alzheimer's disease
    Ochudlo, S
    Targosz, M
    Liberska, A
    Opala, G
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S295 - S295
  • [36] Memantine (Namenda) for moderate to severe Alzheimer's disease
    Ables, AZ
    AMERICAN FAMILY PHYSICIAN, 2004, 69 (06) : 1491 - 1492
  • [37] Memantine in moderate-to-severe Alzheimer's disease
    Bleich, S
    Wiltfang, J
    Kornhuber, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 609 - 610
  • [38] Spotlight on Memantine in Moderate to Severe Alzheimer's Disease
    McKeage, Kate
    DRUGS & AGING, 2010, 27 (02) : 177 - 179
  • [39] The benefits of memantine treatment on behavioral and psychotic symptoms in mild to moderate Alzheimer's disease
    Ladea, M.
    Sinca, M. C.
    Bran, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 138 - 138
  • [40] The safety of combined galantamine-memantine treatment in mild to moderate Alzheimer's disease
    Ramaswamy, K.
    Amatniek, J.
    Crivera, C.
    Rupnow, M.
    Zhu, Y.
    Hammond, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 68 - 68
12345